31 related articles for article (PubMed ID: 9726658)
1. The preferential beta3-adrenoceptor agonist BRL 37344 increases force via beta1-/beta2-adrenoceptors and induces endothelial nitric oxide synthase via beta3-adrenoceptors in human atrial myocardium.
Pott C; Brixius K; Bundkirchen A; Bölck B; Bloch W; Steinritz D; Mehlhorn U; Schwinger RH
Br J Pharmacol; 2003 Feb; 138(3):521-9. PubMed ID: 12569077
[TBL] [Abstract][Full Text] [Related]
2. The β2-adrenoceptor agonist formoterol stimulates mitochondrial biogenesis.
Wills LP; Trager RE; Beeson GC; Lindsey CC; Peterson YK; Beeson CC; Schnellmann RG
J Pharmacol Exp Ther; 2012 Jul; 342(1):106-18. PubMed ID: 22490378
[TBL] [Abstract][Full Text] [Related]
3. β3 Adrenoceptor Agonism Prevents Hyperoxia-Induced Colonic Alterations.
Filippi L; Nardini P; Zizi V; Molino M; Fazi C; Calvani M; Carrozzo F; Cavallaro G; Giuseppetti G; Calosi L; Crociani O; Pini A
Biomolecules; 2023 Dec; 13(12):. PubMed ID: 38136626
[TBL] [Abstract][Full Text] [Related]
4. N-(2,5-Dimethoxy-phen-yl)-4-nitro-benzene-sulfonamide.
Zhang GY; Qian S; Li XC; Wu Y
Acta Crystallogr Sect E Struct Rep Online; 2009 Jul; 65(Pt 8):o1939. PubMed ID: 21583621
[TBL] [Abstract][Full Text] [Related]
5. Insights into the binding modes of human β₃-adrenergic receptor agonists with ligand-based and receptor-based methods.
Jin F; Lu C; Sun X; Li W; Liu G; Tang Y
Mol Divers; 2011 Nov; 15(4):817-31. PubMed ID: 21424594
[TBL] [Abstract][Full Text] [Related]
6. Is the beta3-adrenoceptor (ADRB3) a potential target for uterorelaxant drugs?
Bardou M; Rouget C; Breuiller-Fouché M; Loustalot C; Naline E; Sagot P; Frydman R; Morcillo EJ; Advenier C; Leroy MJ; Morrison JJ
BMC Pregnancy Childbirth; 2007 Jun; 7 Suppl 1(Suppl 1):S14. PubMed ID: 17570158
[TBL] [Abstract][Full Text] [Related]
7. The human near-term myometrial beta 3-adrenoceptor but not the beta 2-adrenoceptor is resistant to desensitisation after sustained agonist stimulation.
Rouget C; Breuiller-Fouché M; Mercier FJ; Leroy MJ; Loustalot C; Naline E; Frydman R; Croci T; Morcillo EJ; Advenier C; Bardou M
Br J Pharmacol; 2004 Mar; 141(5):831-41. PubMed ID: 14769781
[TBL] [Abstract][Full Text] [Related]
8. Functional assessment of beta adrenoceptor subtypes in human colonic circular and longitudinal (taenia coli) smooth muscle.
Manara L; Croci T; Aureggi G; Guagnini F; Maffrand JP; Le Fur G; Mukenge S; Ferla G
Gut; 2000 Sep; 47(3):337-42. PubMed ID: 10940268
[TBL] [Abstract][Full Text] [Related]
9. The odd sibling: features of β3-adrenoceptor pharmacology.
Cernecka H; Sand C; Michel MC
Mol Pharmacol; 2014 Nov; 86(5):479-84. PubMed ID: 24890609
[TBL] [Abstract][Full Text] [Related]
10. Beta 3-adrenoceptors and intestinal motility.
Manara L; Croci T; Landi M
Fundam Clin Pharmacol; 1995; 9(4):332-42. PubMed ID: 8566932
[TBL] [Abstract][Full Text] [Related]
11. In vitro inhibition of human colonic motility with SR 59119A and SR 59104A: evidence of a beta3-adrenoceptor-mediated effect.
Bardou M; Dousset B; Deneux-Tharaux C; Smadja C; Naline E; Chaput JC; Naveau S; Manara L; Croci T; Advenier C
Eur J Pharmacol; 1998 Jul; 353(2-3):281-7. PubMed ID: 9726658
[TBL] [Abstract][Full Text] [Related]
12. Influence of beta-adrenoceptor agonists on the pulmonary circulation. Effects of a beta3-adrenoceptor antagonist, SR 59230A.
Dumas M; Dumas JP; Bardou M; Rochette L; Advenier C; Giudicelli JF
Eur J Pharmacol; 1998 May; 348(2-3):223-8. PubMed ID: 9652337
[TBL] [Abstract][Full Text] [Related]
13. Functional, biochemical and molecular biological evidence for a possible beta(3)-adrenoceptor in human near-term myometrium.
Bardou M; Loustalot C; Cortijo J; Simon B; Naline E; Dumas M; Esteve S; Croci T; Chalon P; Frydman R; Sagot P; Manara L; Morcillo EJ; Advenier C
Br J Pharmacol; 2000 Aug; 130(8):1960-6. PubMed ID: 10952688
[TBL] [Abstract][Full Text] [Related]
14. Inhibition by SR 59119A of isoprenaline-, forskolin- and VIP-induced relaxation of human isolated bronchi.
Naline E; Bardou M; Devillier P; Molimard M; Dumas M; Chalon P; Manara L; Advenier C
Pulm Pharmacol Ther; 2000; 13(4):167-74. PubMed ID: 10930355
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
